维普中文期刊产品整合服务
180篇 您的检索式:作者名="OZOLS RF"
    题名 作者 年代 出处 被引量
1Gemcitabine and Carboplatin in second-line ovarian cancer显示文摘Ozols RF 2005Semin Oncol2005,32,46:1
2Update of the NCCN ovarian cancer practice guidelines显示文摘Ozols RF 1997Oncology (Huntingt)1997,11,11:1
3Treatment goals in ovarian cancer显示文摘Ozols RF 2005Int J Gyne-col Cancer2005,15,1:1
4Phase Ⅲ trial of earbo platin and paolitaxel compared with eisplatin and paclitaxel in patients with optimally reseeted stage Ⅲ ovarian cancer:a Gynecologic Oneology Group study显示文摘Ozols RF Bundy BN Greer BE 2003J Clin Oncol2003,21,17:1
5Quantitation of cis-diamminedichloroplatinum Ⅱ (cis- platin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy显示文摘Reed E Yuspa SH Zwelling LA Ozols RF Poirier MC 1986J Clin Invest1986,77,2:1
6Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving pla- tinum-based chemotherapy显示文摘Reed E Ozols RF Tarone R Yuspa SH Poirier MC 1987Proc Natl Acad Sci USA1987,84,14:1
7Symptoms of ovarian cancer-Where to set the bar显示文摘Daly MB Ozols RF 2004JAMA2004,291,22:1
8Systemic therapy for ovarian cancer:current status and new treatments显示文摘Ozols RF 2006Semin Oncol2006,33,:1
9Phase III trial of carboplatin and paclitaxel compared with cisplatin and pa- clitaxel in patients with optimally resected stage III ovarian cancer:a Gynecologic Oncology Group study显示文摘Ozols RF Bundy BN Greer BE 2003J Clin On- cel2003,21,17:1
10Update on Gynecologic 0ncology Group (GOG) trims in ovarian cancer显示文摘Ozols RF 2004Cancer Invest2004,22,2:1
11Focus on epithelial ovarian cancer 显示文摘Ozols RF Bookman MA Cormolly DC 2004Cancer Cell2004,5,1:1
12Mechanisms of drug resistance in ovarian cancer显示文摘 Ozols RF Hamilton TC 1993Cancer1993,71,2:1
13Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening-A Report from the American Society of Clinical Oncology显示文摘Ozols RF Herbst RS Colson YL 2007J Clin Oncol2007,25,1:1
14Phase Ⅲ trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage Ⅲ ovarian cancer:a Gynecologic Oncology Group study显示文摘Ozols RF Bundy BN Greer BE 2003J Clin Oncol2003,21,17:1
15Symptoms of ovarian cancer-where to set the bar? 显示文摘Daly MB Ozols RF 2004JAMA2004,291,22:1
16Chemotherapy of ovarian cancer显示文摘Ozols RF Young RC 1984Se-min Oncol1984,11,3:1
17Focus on epithelial ovarian cancer显示文摘Ozols RF Bookman MA Connolly DC 2004Cancer Cell2004,5,1:1
18Focus on ep- ithelial ovarian cancer显示文摘Ozols RF Bookman MA Connolly DC 2004Cancer Cell2004,5,1:1
19Phase III trial of carbo-platin and paclitaxel compared with cisplatin and paclitaxel in pa-tients with optimally resected stage III ovarian cancer:a Gyneco-logic Oncology Group study显示文摘Ozols RF Bundy BN Greer BE 2003J Clin Oncol2003,21,17:1
20Focus on epi- thelial ovarian cancer显示文摘Ozols RF Bookman MA Connolly DC 2005Cancer Cell2005,5,:1
返回顶部 每页显示:
共9页 首页 上一页 第1页 下一页 末页 /9 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费